We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Advanced Visualization and Analysis Suite for Spectral CT Receives FDA Clearance

By MedImaging International staff writers
Posted on 24 Sep 2015
Print article
An advanced clinical applications suite for spectral Computed Tomography (CT) has received US Food and Drug Administration (FDA) 510(k) clearance for the US.

The suite of advanced visualization and analysis tools was designed to give clinicians on-demand spectral information, and clinical decision support to analyze incidental findings, without the need for additional scans and additional radiation exposure for the patient.

The Spectral Diagnostic Suite (SpDS) was designed by Royal Philips (Amsterdam, the Netherlands) for the Philips IQon Spectral CT scanner. The SpDS includes Spectral enhanced Comprehensive Cardiac Analysis (sCCA), Spectral enhanced Advanced Vessel Analysis (sAVA), Spectral enhanced Tumor Tracking (sTT), and enables clinicians to view and analyze spectral datasets in a reading room, on a Picture Archiving and Communication Systems (PACS), or remotely. The Philips Spectral suite also enables clinicians to perform segmentation, on different energy levels, advanced fusion, and more detailed comparison of images.

Mikael Strindlund, senior vice president & general manager of CT at Philips, said, "The game-changing capabilities of the Spectral Diagnostic Suite represent our ongoing commitment to drive advanced innovation in medical imaging to improve clinical output and diagnostic confidence, leading to better care for patients at lower dose exposure. Providing clinicians with additional data to help support the right clinical decisions while improving workflow and patient experience, is at the core of everything we do."

Related Links:

Philips Healthcare


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray Detector
FDR-D-EVO III
New
C-Arm with FPD
Digiscan V20 / V30
Laptop Ultrasound Scanner
PL-3018

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.